Full name
GILEAD SCIENCES POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
GILEAD SCIENCES POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. POSTĘPU 17A, 02-676 WARSZAWA
TAX ID1070015800
Rate company:
GILEAD SCIENCES POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID1070015800
KRS0000350550
Share capital50,000.00 zł
address
UL. POSTĘPU 17A, 02-676 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
1070015800
REGON
142330322
KRS
0000350550
Legal form
limited liability company
Register Address
UL. POSTĘPU 17A, 02-676 WARSZAWA
Date of registration in KRS
2010-03-08
Date of commencement of economic activity
2010-03-08
Act signature
WA.XIII NS-REJ.KRS/13210/25/760
Pkd codes
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
46.90.Z - Non-specialized wholesale trade
47.19.Z - Retail trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.78.Z - Retail sale of other new products
47.91.Z - Intermediary retail sale, non-specialized
63.99.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
72.19.Z - Scientific research and development activities
Payer VAT status
Active
Vat list bank account(s)
PL24 1090 2851 0000 0001 3733 2473 
PL37 1880 0009 0000 0011 0204 7000 PL44 1090 2851 0000 0001 3733 2501 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 28,7 | 29 | 16,2 | -44 |
EBITDA | 37 | 23 | 18,3 | -20,4 |
Short time liabilities | 226,8 | 65,4 | 215,1 | 228,7 |
Equity capital | 94,2 | 117,8 | 130,4 | 10,8 |
Operating profit (EBIT) | 35,4 | 21,2 | 16,3 | -23,2 |
Assets | 337 | 205,6 | 397,6 | 93,4 |
Net profit (loss) | 22 | 23,5 | 12,7 | -46 |
Cash | 46,6 | 29,4 | 146,5 | 398,3 |
Net income from sale | 1009,4 | 680,8 | 466,5 | -31,5 |
Liabilities and provisions for liabilities | 242,7 | 87,9 | 267,2 | 204,1 |
Working assets | 325,5 | 194,5 | 374 | 92,3 |
Depreciation | 1,7 | 1,8 | 2 | 12,9 |
% | % | % | p.p. | |
Profitability of capital | 23,4 | 20 | 9,7 | -10,3 |
Equity capital to total assets | 28 | 57,3 | 32,8 | -24,5 |
Gross profit margin | 2,8 | 4,3 | 3,5 | -0,8 |
EBITDA Margin | 3,7 | 3,4 | 3,9 | 0,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 82 | 35 | 168 | 133 |
Current financial liquidity indicator | 1.4195654392242432 | 2.5924630165100098 | 1.5100315809249878 | -1,1 |
Net dept to EBITDA | -1.1158086061477661 | -1.0590347051620483 | -7.634456157684326 | -6,5 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (3)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Red Med Poland Sp. z o.o.
Chorzów
PROMEDIQ A Sp. z o.o.
Gdynia
Wamed-Lab sp. z o.o.
Warszawa
Cannabis Sklep
Świętochłowice, woj. śląskie, Polska
CYTOGEN-POLSKA
ŁÓDŹ
UROMED POLAND
TORUŃ
DKR Medical sp. z o.o.
Poznań
BEATA BOGDZIEWICZ AB-MED
Tychy